PMID- 25505180 OWN - NLM STAT- MEDLINE DCOM- 20150505 LR - 20220112 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 290 IP - 6 DP - 2015 Feb 6 TI - The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. PG - 3455-67 LID - 10.1074/jbc.M114.605253 [doi] AB - Prion diseases are a group of transmissible, fatal neurodegenerative disorders associated with the misfolding of the host-encoded prion protein, PrP(C), into a disease-associated form, PrP(Sc). The transmissible prion agent is principally formed of PrP(Sc) itself and is associated with extracellular vesicles known as exosomes. Exosomes are released from cells both in vitro and in vivo, and have been proposed as a mechanism by which prions spread intercellularly. The biogenesis of exosomes occurs within the endosomal system, through formation of intraluminal vesicles (ILVs), which are subsequently released from cells as exosomes. ILV formation is known to be regulated by the endosomal sorting complexes required for transport (ESCRT) machinery, although an alternative neutral sphingomyelinase (nSMase) pathway has been suggested to also regulate this process. Here, we investigate a role for the nSMase pathway in exosome biogenesis and packaging of PrP into these vesicles. Inhibition of the nSMase pathway using GW4869 revealed a role for the nSMase pathway in both exosome formation and PrP packaging. In agreement, targeted knockdown of nSMase1 and nSMase2 in mouse neurons using lentivirus-mediated RNAi also decreases exosome release, demonstrating the nSMase pathway regulates the biogenesis and release of exosomes. We also demonstrate that PrP(C) packaging is dependent on nSMase2, whereas the packaging of disease-associated PrP(Sc) into exosomes occurs independently of nSMase2. These findings provide further insight into prion transmission and identify a pathway which directly assists exosome-mediated transmission of prions. CI - (c) 2015 by The American Society for Biochemistry and Molecular Biology, Inc. FAU - Guo, Belinda B AU - Guo BB AD - From the Department of Biochemistry and Molecular Biology, The University of Melbourne, VIC 3010, Australia and the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, VIC 3010, Australia. FAU - Bellingham, Shayne A AU - Bellingham SA AD - From the Department of Biochemistry and Molecular Biology, The University of Melbourne, VIC 3010, Australia and the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, VIC 3010, Australia shayneb@unimelb.edu.au. FAU - Hill, Andrew F AU - Hill AF AD - From the Department of Biochemistry and Molecular Biology, The University of Melbourne, VIC 3010, Australia and the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, VIC 3010, Australia a.hill@unimelb.edu.au. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141210 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Prions) RN - EC 3.1.4.12 (Smpd3 protein, mouse) RN - EC 3.1.4.12 (Sphingomyelin Phosphodiesterase) SB - IM MH - Animals MH - Cell Line MH - Exosomes/*metabolism MH - Humans MH - Mice MH - Neurons/metabolism MH - Prions/*metabolism MH - Sphingomyelin Phosphodiesterase/genetics/*metabolism PMC - PMC4319014 OTO - NOTNLM OT - Ceramide OT - Exosome OT - Exosomes OT - Extracellular Vesicles OT - Neutral Sphingomyelinase OT - Prion OT - Prion Disease OT - nSMase2 EDAT- 2014/12/17 06:00 MHDA- 2015/05/06 06:00 PMCR- 2016/02/06 CRDT- 2014/12/16 06:00 PHST- 2014/12/16 06:00 [entrez] PHST- 2014/12/17 06:00 [pubmed] PHST- 2015/05/06 06:00 [medline] PHST- 2016/02/06 00:00 [pmc-release] AID - S0021-9258(20)49193-8 [pii] AID - M114.605253 [pii] AID - 10.1074/jbc.M114.605253 [doi] PST - ppublish SO - J Biol Chem. 2015 Feb 6;290(6):3455-67. doi: 10.1074/jbc.M114.605253. Epub 2014 Dec 10.